A Oneindia Venture
News Personal finance Gold rates Silver rates Mutual funds IPO MSME
Gold Rates
Silver Rates
Platinum Rates
Fuel Price
Holidays
Banking
Lottery
Calculators
Savings Scheme
Get Updates
Get notified about market trends, financial advice, and investment tips!
English हिन्दी ಕನ್ನಡ മലയാളം தமிழ் తెలుగు
Sensex 73,319.55 +0.25% ↑ Nifty 22,713.10 +0.15% ↑ 22k Gold ₹ 13,835/gm Silver ₹ 2,50,000/kg Petrol ₹ 103.50 Diesel ₹ 90.03 LPG ₹ 912.50 Crude Oil $ 109.24 USD ₹ 92.71
Sensex 73,319.55 +0.25% ↑ Nifty 22,713.10 +0.15% ↑ 22k Gold ₹ 13,835/gm Silver ₹ 2,50,000/kg Petrol ₹ 103.50 Diesel ₹ 90.03 LPG ₹ 912.50 Crude Oil $ 109.24 USD ₹ 92.71
Home News Business
Aurobindo Pharma Rallies As Company Gets US FDA Approval
By
Add as a preferred source on Google

Shares in Aurobindo Pharma was trading 2 per cent higher after the company said it has received USFDA's approval for Sildenafil Tablets, 20mg.

The product is expected to be launched by Q4 FY 2015-16. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) REVATIO (sildenafil citrate) Tablets 20 mg of Pfizer, Inc.

aurobindo
Aurobindo Pharma: Quotes, News
BSE 1335.95BSE Quote6.15 (-0.46%)
NSE 1333.70NSE Quote8.4 (-0.63%)
Sildenafil Tablets are used in the treatment of pulmonary arterial hypertension (high blood pressure in the lungs). The approved product has an estimated market size of US$80 million for the twelve months ending September 2015 according to IMS.

This is the 51st ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products. Aurobindo now has a total of 219 ANDA approvals (190 Final approvals including 10 from Aurolife Pharma LLC and 29 Tentative approvals) from USFDA.

GoodReturns.in

Share This Article
Story first published: Monday, November 23, 2015, 12:10 [IST]
See More On: aurobindo pharma
Other articles published on Nov 23, 2015

More From GoodReturns

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
Sign Out